Sex differences in pediatric infectious diseases

Journal of Infectious Diseases

Volumn 209, Issue SUPPL. 3, 2014, Pages

  Muenchhoff, Maximilian ^a   Goulder, Philip J R ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

gender; infections; pediatric; sex

Indexed keywords

CYTOKINE; SEX HORMONE;

ADENOVIRUS; ARTICLE; AUTOIMMUNITY; BACTERIAL INFECTION; BOTULISM; BRUCELLOSIS; CHAGAS DISEASE; CHICKENPOX; CHILD; COXSACKIE VIRUS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FEMALE; HAEMOPHILUS INFLUENZAE; HELPER CELL; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PARVOVIRUS B19; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INCIDENCE; INFECTION; LEISHMANIASIS; LEPTOSPIROSIS; LOWER RESPIRATORY TRACT INFECTION; LYMPHATIC FILARIASIS; MALE; MEASLES; MENINGOCOCCOSIS; MORBIDITY; MORTALITY; MUMPS; MYCOPLASMA PNEUMONIAE; ONCHOCERCIASIS; PARASITOSIS; PERTUSSIS; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SCHISTOSOMIASIS; SEX DIFFERENCE; STREPTOCOCCUS GROUP A; TH1 CELL; TH2 CELL; TRYPANOSOMIASIS; TUBERCULOSIS;

GENDER; INFECTIONS; PEDIATRIC; SEX;

ADOLESCENT; AGING; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INFANT; MALE; SEX FACTORS;

EID: 84903534770     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu232     Document Type: Article

References (62)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2095-128.
2. Anker M. Addressing sex and gender in epidemic-prone infectious diseases. Geneva, Switzerland: World Health Organization, 2007.
3. Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 2008; 8:737-44.
4. Amur S, Parekh A, Mummaneni P. Sex differences and genomics in autoimmune diseases. J Autoimmun 2012; 38:J254-65.
5. Prendergast AJ, Klenerman P, Goulder PJ. The impact of differential antiviral immunity in children and adults. Nat Rev Immunol 2012; 12:636-48.
6. Kollmann TR, Crabtree J, Rein-Weston A, et al. Neonatal innate TLRmediated responses are distinct from those of adults. J Immunol 2009; 183:7150-60.
7. Siegrist CA. The challenges of vaccine responses in early life: selected examples. J Comp Pathol 2007; 137(Suppl 1):S4-9.
8. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7:379-90.
9. Ahmed R, Oldstone MB, Palese P. Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nat Immunol 2007; 8:1188-93.
10. Anderson RM, May RM, Anderson B. Infectious diseases of humans: dynamics and control. Oxford and New York: Oxford University Press, 1991.
11. Ober C, Loisel DA, Gilad Y. Sex-specific genetic architecture of human disease. Nat Rev Genet 2008; 9:911-22.
12. Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update 2005; 11:411-23.
13. Araneo BA, Dowell T, Diegel M, Daynes RA. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T cells. Blood 1991; 78:688-99.
14. Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007; 28:521-74.
15. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010; 375:1545-55.
16. Picone O, Costa JM, Dejean A, Ville Y. Is fetal gender a risk factor for severe congenital cytomegalovirus infection? Prenat Diagn 2005; 25:34-8.
17. Haberling DL, Holman RC, Paddock CD, Murphy TV. Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004. Pediatr Infect Dis J 2009; 28:194-8.
18. Mossong J, O'Callaghan CJ, Ratnam S. Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population. Vaccine 2000; 19:523-9.
19. Green MS. The male predominance in the incidence of infectious diseases in children: a postulated explanation for disparities in the literature. Int J Epidemiol 1992; 21:381-6.
20. Garenne M. Sex differences in measles mortality: a world review. Int J Epidemiol 1994; 23:632-42.
21. Gutierrez J, Issacson RS, Koppel BS. Subacute sclerosing panencephalitis: an update. Dev Med Child Neurol 2010; 52:901-7.
22. Manayani DJ, Abraham M, Gnanamuthu C, Solomon T, Alexander M, Sridharan G. SSPE - the continuing challenge: a study based on serological evidence from a tertiary care centre in India. Indian J Med Microbiol 2002; 20:16-8.
23. Dominguez A, Plans P, Costa J, et al. Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis 2006; 25:310-7.
24. Hviid A, Rubin S, Muhlemann K. Mumps. Lancet 2008; 371:932-44.
25. Segal AO, Crighton EJ, Moineddin R, Mamdani M, Upshur RE. Croup hospitalizations in Ontario: a 14-year time-series analysis. Pediatrics 2005; 116:51-5.
26. Klein NP, Holmes TH, Sharp MA, et al. Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults. Vaccine 2006; 24:5913-8.
27. Ruel TD, Zanoni BC, Ssewanyana I, et al. Sex differences in HIV RNA level and CD4 cell percentage during childhood. Clin Infect Dis 2011; 53:592-9.
28. OrntoftNW, Thorsen K, Benn CS, et al. Leukocyte transcript alterations in West-African girls following a booster vaccination with diphtheriatetanus- pertussis vaccine. Scand J Clin Lab Invest 2013; 73:349-54.
29. Marinda E, Humphrey JH, Iliff PJ, et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 2007; 26:519-26.
30. Lin MH, Chang PF, Fong WK, Yen CW, Hung KL, Lin SJ. Epidemiological and clinical features of group A Streptococcus pharyngitis in children. Acta Paediatr Taiwan 2003; 44:274-8.
31. Breda L, Miulli E, Marzetti V, Chiarelli F, Marcovecchio ML. Rheumatic fever: a disease still to be kept in mind. Rheumatology (Oxford) 2013; 52:953.
32. Ravisha MS, Tullu MS, Kamat JR. Rheumatic fever and rheumatic heart disease: clinical profile of 550 cases in India. Arch Med Res 2003; 34:382-7.
33. Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE. Resurgence of pertussis in Europe. Pediatr Infect Dis J 2005; 24:761-5.
34. Klein SL. Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases. Bioessays 2012; 34:1050-9.
35. McCarthy M, Auger D, Whittemore SR. Human cytomegalovirus causes productive infection and neuronal injury in differentiating fetal human central nervous system neuroepithelial precursor cells. J Hum Virol 2000; 3:215-28.
36. Gabrielli L, Bonasoni MP, Santini D, et al. Congenital cytomegalovirus infection: patterns of fetal brain damage. Clin Microbiol Infect 2012; 18: E419-27.
37. van de Berg PJ, Yong SL, Remmerswaal EB, van Lier RA, ten Berge IJ. Cytomegalovirus-induced effector T cells cause endothelial cell damage. Clin Vaccine Immunol 2012; 19:772-9.
38. Villacres MC, Longmate J, Auge C, Diamond DJ. Predominant type 1 CMV-specific memory T-helper response in humans: evidence for gender differences in cytokine secretion. Hum Immunol 2004; 65:476-85.
39. Knudsen KM, Aaby P, Whittle H, et al. Child mortality following standard, medium or high titre measles immunization in West Africa. Int J Epidemiol 1996; 25:665-73.
40. de Melker H, Pebody RG, Edmunds WJ, et al. The seroepidemiology of measles in Western Europe. Epidemiol Infect 2001; 126:249-59.
41. Griffin DE, Ward BJ, Esolen LM. Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J Infect Dis 1994; 170(Suppl 1):S24-31.
42. Hill K, Upchurch DM. Gender differences in child health: evidence from the demographic and health surveys. Population Dev Rev 1995; 25:127-51.
43. Borchers AT, Chang C, Gershwin ME, Gershwin LJ. Respiratory syncytial virus - a comprehensive review. Clin Rev Allergy Immunol 2013; 45:331-79.
44. Openshaw PJ, Tregoning JS. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev 2005; 18:541-55.
45. Kim HW, Canchola JG, Brandt CD, et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 1969; 89:422-34.
46. Graham BS, Bunton LA, Wright PF, Karzon DT. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 1991; 88:1026-33.
47. Nagayama Y, Tsubaki T, Nakayama S, et al. Gender analysis in acute bronchiolitis due to respiratory syncytial virus. Pediatr Allergy Immunol 2006; 17:29-36.
48. Ronen O, Malhotra A, Pillar G. Influence of gender and age on upperairway length during development. Pediatrics 2007; 120:e1028-34.
49. Fleming DM, Cross KW, CobbWA, Chapman RS. Gender difference in the incidence of shingles. Epidemiol Infect 2004; 132:1-5.
50. Bunders M, Cortina-Borja M, Newell ML. Age-related standards for total lymphocyte, CD4+ and CD8+ T cell counts in children born in Europe. Pediatr Infect Dis J 2005; 24:595-600.
51. Falagas ME, Mourtzoukou EG, Vardakas KZ. Sex differences in the incidence and severity of respiratory tract infections. Respir Med 2007; 101:1845-63.
52. Eshima N, Tokumaru O, Hara S, et al. Age-specific sex-related differences in infections: a statistical analysis of national surveillance data in Japan. PloS One 2012; 7:e42261.
53. Pollard AJ, Green C, Sadarangani M, Snape MD. Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease. Arch Dis Child 2013; 98:248-51.
54. Shann F. The non-specific effects of vaccines. Arch Dis Child 2010; 95:662-7.
55. Aaby P, Roth A, Ravn H, et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis 2011; 204:245-52.
56. Aaby P, Martins CL, Garly ML, et al. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. BMJ 2010; 341:c6495.
57. Kleinnijenhuis J, Quintin J, Preijers F, et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S Am 2012; 109:17537-42.
58. Wen H, Dou Y, Hogaboam CM, Kunkel SL. Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response. Blood 2008; 111:1797-804.
59. Aaby P, Ravn H, Roth A, et al. Early diphtheria-tetanus-pertussis vaccination associated with higher female mortality and no difference in male mortality in a cohort of low birthweight children: an observational study within a randomised trial. Arch Dis Child 2012; 97:685-91.
60. Guerra-Silveira F, Abad-Franch F. Sex bias in infectious disease epidemiology: patterns and processes. PLoS One 2013; 8:e62390.
61. Alexander J, Bryson K. T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunol Lett 2005; 99:17-23.
62. Snider H, Lezama-Davila C, Alexander J, Satoskar AR. Sex hormones and modulation of immunity against leishmaniasis. Neuroimmunomodulation 2009; 16:106-13.